年货礼盒的本质，是一种延续千年的"仪式性消费"，它承载着情感、社交与文化价值，是对一年辛劳的犒赏，也是亲 友之间心意的连接。 01 消费之变——年货礼盒的"价值回归" 新年伊始，食品品牌的年货季又来了。但今年的空气里，嗅到的不仅是年味，还有一丝愈发浓重的矛盾感。 一边，是品牌在年前使尽浑身解数：礼盒包装越来越华丽，品牌故事越讲越动人，只为挤破头钻进各种渠道的货架。 而另一边，消费者却似乎更"冷静"了——他们在琳琅满目的年货前驻足、比价、犹豫，然后许多人转身走向了胖东 来、山姆这类会员制商超，排着队把它们的自营商品放进了购物车。 然而，时代在变，承载这份仪式感的情感通货也正在经历一次彻底的升级换代。华丽的包装与吉祥的寓意，已不足以 说服新一代消费者。 他们开始冷静地追问一个本质问题：这份年货本身，除了节日的美好寓意，它是否还有过硬的内核？ 消费决策的焦点，也从外在的包装与动人的故事，回归到产品内在那些可以触摸、可以验证的"干货"。 要在这场年货战争中赢得更多用户的心，品牌越来越需要为消费者提供一个硬核理由。竞争也已从浮于表面的营销， 沉淀到产品本身的深度革新。年货的胜利，本质上需要产品"硬通货"价值的胜利。 这 ...

Core Insights - The article discusses the evolving landscape of consumer behavior regarding traditional New Year gift boxes, highlighting a shift towards more rational purchasing decisions as consumers prioritize product value over packaging and marketing narratives [2][3]. Group 1: Shifts in Consumer Behavior - The essence of New Year gift boxes is rooted in ceremonial consumption, representing emotional, social, and cultural values, but consumers are increasingly questioning the intrinsic value of these products beyond their festive symbolism [3]. - Consumers are gravitating towards membership-based supermarkets like Pinduoduo and Sam's Club, indicating a preference for self-branded products that offer perceived value [2]. Group 2: Product Innovation Trends - Brands must provide compelling reasons for consumers to choose their products, leading to a focus on deep product innovation rather than superficial marketing [5]. - The first key transformation is the precise definition of "functional value," where products must clearly address specific consumer needs, exemplified by Danone's targeted offerings for GLP-1 drug users [5][6]. - The second transformation involves AI-driven flavor and experience reconstruction, as seen in Genki Forest's use of AI for over 500 flavor iterations to enhance product appeal [10]. - The third transformation is the modernization of "food as medicine," with brands like Dong'e Ejiao offering convenient, ready-to-eat products that fit contemporary lifestyles [12]. - The fourth transformation focuses on value sourcing from the supply chain, where brands that control high-quality raw materials and production processes gain a competitive edge [14]. Group 3: Market Trust and Experience - As product innovation becomes a necessity, brands face the challenge of gaining market visibility and trust in a fragmented information landscape [16]. - Successful brands are returning to physical spaces to create tangible experiences that foster consumer trust, as demonstrated by the popularity of membership stores [16]. - The concept of "consensus pre-sale" is emerging, where brands validate their products through community engagement or industry exhibitions before market launch, ensuring they enter the market with established consumer trust [25][26]. Group 4: The Role of Industry Exhibitions - Industry exhibitions serve as critical platforms for brands to validate trends, calibrate value, and build trust, allowing companies to quickly gather insights and feedback from industry peers and consumers [29]. - Exhibitions facilitate rapid trust-building through direct interactions, which are essential for establishing commercial partnerships and reducing risks in cross-border trade [33]. - New brands leverage exhibitions to connect with potential partners and streamline their innovation processes, enhancing their ability to bring products to market effectively [33].

Core Viewpoint - Dong-E E-Jiao has confirmed its absence from the current bull market, with a year-to-date decline of 18% as of December 22, 2025. The company needs to identify new growth points, such as E-Jiao paste, male products, and international expansion, to regain momentum [1][12][13]. Stock Performance - As of December 22, 2025, Dong-E E-Jiao's stock closed at 49.25 yuan, reflecting a total market capitalization of 31.72 billion yuan. The stock has seen an 18% decline since the beginning of the year, contrasting sharply with the overall A-share market, where over 4,300 stocks recorded positive gains [2][14]. - The company has initiated a share buyback plan, intending to use 100 million to 200 million yuan to repurchase shares at a maximum price of 72.08 yuan per share. This is expected to involve the repurchase of approximately 138,730 to 277,470 shares, representing 0.22% to 0.43% of the total share capital [2][15]. Dividend Policy - Dong-E E-Jiao plans to distribute a cash dividend of 12.69 yuan per 10 shares, totaling approximately 817 million yuan, which indicates a high payout ratio. From 2020 to 2024, the company has consistently maintained a high dividend payout ratio, with a total cash dividend of 1.96 billion yuan in 2020, increasing to 15.55 billion yuan in 2024 [3][15][16]. Historical Context - Dong-E E-Jiao was once regarded as the "Moutai of medicine," experiencing a long-term bull market. However, after a series of price increases that led to a disconnect between product pricing and consumer demand, the company faced significant challenges, including a net profit loss of 455 million yuan in 2019 [4][18]. - The leadership transition from Qin Yufeng to Gao Dengfeng in 2020 marked a shift in strategy, with a renewed focus on E-Jiao paste, which has seen significant sales growth due to favorable policy changes [6][19][20]. Recent Developments - The company has launched new products targeting male consumers, such as the "Royal Weichang 1619" brand, and has made strategic acquisitions in the male health supplement sector [9][22]. - Dong-E E-Jiao is also expanding its international presence, having acquired Huaren Pharmaceutical Trading (Hong Kong) Co., Ltd. and established partnerships in Southeast Asia, although overseas revenue remains a small portion of total income [10][24].

Core Viewpoint - The concept of "food and medicine sharing the same source" is gaining popularity, leading to increased demand for health products, particularly ready-to-eat Ejiao products, driven by various consumer demographics including the elderly, women, and Gen Z [1][8]. Market Overview - The ready-to-eat Ejiao market in China is projected to reach a scale of 54.3 billion yuan in 2024, representing a year-on-year growth of 22.3%, accounting for 25% of the overall ready-to-eat health product market [1][8]. - Ready-to-eat Ejiao is produced through optimized formulations and improved processes, making it convenient for modern lifestyles [2][3]. Market Policies - Recent policies emphasize food safety and quality control across all stages of production, processing, and distribution of ready-to-eat Ejiao, promoting a shift towards standardized and high-quality industry practices [4][5]. Industry Chain - The upstream of the ready-to-eat Ejiao industry includes suppliers of key raw materials such as donkey hide, black sesame, walnuts, red dates, honey, and rock sugar, while the midstream consists of production companies, and the downstream includes various sales channels [6][7]. Current Development - The demand for ready-to-eat Ejiao is expanding beyond traditional consumers to include working professionals and younger generations, with consumption scenarios evolving to include daily snacks and gift-giving [8][9]. Competitive Landscape - The ready-to-eat Ejiao market is characterized by a concentrated competitive structure, dominated by two major players, Dong'e Ejiao and Fupai Ejiao, which control key raw material supplies and have established strong brand loyalty [10]. - Dong'e Ejiao reported a revenue of 3.051 billion yuan in the first half of 2025, with 93.2% of this coming from Ejiao and related products [11]. - Fupai Ejiao achieved a revenue of 2.104 billion yuan in 2024, marking a 5% increase, with over 40% of sales coming from non-Ejiao block products [12]. Future Trends - The ready-to-eat Ejiao product line is expected to diversify further, introducing more portable and snack-like options, while also targeting specific consumer needs such as prenatal nutrition and weight management [13]. - The international market for ready-to-eat Ejiao is anticipated to expand, initially targeting regions with high Chinese populations and gradually moving towards Western markets [13].

Group 1 - The company Dong-E E-Jiao has been awarded the title of "National Advanced Unit for Mass Sports" for the period of 2021-2024 by the General Administration of Sport of China, recognizing its efforts in promoting health services and mass fitness activities [1][3] - Dong-E E-Jiao has actively implemented the "Strong Sports Nation" strategy and has committed to safeguarding public health by organizing various employee sports activities and supporting high-quality development in sports [3] - Starting in 2024, Dong-E E-Jiao will establish a strategic partnership with the Shandong Provincial Sports Bureau, sponsoring the Shandong team in the National Super League and the Shandong Marathon, while also becoming a strategic partner for the Shandong delegation at the 15th National Games [3] Group 2 - The company's core products, including "Dong-E E-Jiao," "Compound E-Jiao Syrup," and "Peach Blossom Princess E-Jiao Cake," have been designated as the official products for the Shandong sports delegation at the 15th National Games [3] - Dong-E E-Jiao is planning to build employee health service centers and is focused on enhancing the physical fitness and health levels of its employees through various sports activities [3] - The company aims to integrate traditional Chinese medicine with sports health initiatives, driving innovation in the TCM sector and contributing to the national health development strategy [3]

Core Insights - Dong-E E-Jiao Co., Ltd. has been designated as a strategic partner by the Shandong Sports Bureau, providing comprehensive support to the Shandong delegation during the 15th National Games [1][2] - The company’s three core products—Dong-E E-Jiao, Compound E-Jiao Syrup, and Peach Blossom E-Jiao Cake—were awarded the title of "Designated Products for the Shandong Sports Delegation" [1][2] - Dong-E E-Jiao emphasizes its commitment to supporting local sports development as part of its corporate social responsibility, aligning its growth with regional sports initiatives [1] Company Initiatives - During the current National Games cycle, Dong-E E-Jiao has focused on enhancing its research system, product quality management, and supply chain capabilities to support sports initiatives [2] - The inclusion of its three core products in the designated product matrix reflects the company's comprehensive strength in quality systems, standard management, and supply chain capabilities [2] - Dong-E E-Jiao aims to continue integrating traditional Chinese medicine with modern sports health, driving innovation and expanding its collaboration with the sports health system [2]

Core Viewpoint - The company demonstrated a healthy development trend in the first three quarters of 2025, with steady growth in core businesses and optimized R&D investment and expense control [12]. Financial Performance - In the first three quarters, the company achieved an operating income of 4.766 billion yuan, a year-on-year increase of 10.10% [1] - The net profit attributable to shareholders reached 1.274 billion yuan, up 10.58% year-on-year [1] - The net cash flow from operating activities was 1.31 billion yuan, with a basic earnings per share of 1.9781 yuan, reflecting a 10.35% increase [1] - The gross profit margin improved by 3.33 percentage points to 73.69%, driven by stable growth in core product lines and a focus on high-margin categories [1] Cost Management - The company maintained reasonable control over sales and management expenses, with R&D expenses increasing by 62.29% to 145 million yuan, emphasizing the importance of technological innovation and long-term competitiveness [1][2]. Product Performance - The core product matrix continued to perform well, with significant growth in the sales of Ejiao blocks, compound Ejiao syrup, and Taohua Ji Ejiao cake, further consolidating market share [4][5] - Ejiao blocks maintained a leading position in the OTC market, while compound Ejiao syrup gained recognition as a popular product in both hospital and retail channels [5] - The Taohua Ji Ejiao cake successfully attracted female consumers through product innovation and marketing strategies [5] Market Expansion - The company is actively targeting the silver economy and men's health sectors, with plans to innovate product forms and expand into the middle-aged and elderly markets [7] - The men's health product line includes unique formulations aimed at addressing common health issues, positioning the company for future growth [7] Brand Value - The company was recognized for its brand value, ranking 11th on the 2025 Health China Brand Value List with a brand value of 19.43 billion yuan [8] - It also received accolades for its innovative marketing strategies and was listed among the top 100 most valuable Chinese brands [8] Sustainable Development - The company is committed to sustainable practices, including agricultural development and ecological protection, which earned it the title of "Most Socially Responsible Listed Company" at the 2025 Phoenix Star Awards [9] Strategic Partnerships - The partnership with China Resources Group enhances the company's strategic transformation and ecological construction, facilitating investment in traditional Chinese medicine and international market exploration [11] - The establishment of a 1 billion yuan pharmaceutical industry investment fund aims to support innovative projects in the health sector [11] Future Outlook - The company is well-positioned for future growth with its strategic focus on the silver economy and men's health, alongside the support from its strategic partner, which will enhance its competitive edge in the traditional Chinese medicine market [12]

Core Insights - Dong'e Ejiao reported a revenue of 4.766 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 10.1%, with a net profit of 1.274 billion yuan, up 10.58% [1] - The company's gross profit margin increased by 3.33 percentage points to 73.69% during the reporting period, attributed to stable growth in core product lines and a focus on high-margin categories [1] Product Performance - The core product matrix, including Ejiao blocks and compound Ejiao syrup, continued to support the company's growth, with both product lines showing steady growth and increased market share [2] - Ejiao blocks maintained a leading position in the OTC market, with ongoing strategies to attract diverse consumer groups through high-end and youth-oriented marketing [2] - The introduction of low-sugar certified products under the "Peach Blossom Princess Ejiao Cake" brand has effectively increased repurchase rates among female consumers [2] Market Expansion Strategies - The company is actively targeting the silver economy and men's health sectors, with Ejiao blocks being recognized for their blood-nourishing properties among the elderly [2] - The "Royal Weichang 1619" brand focuses on men's health, addressing issues like kidney deficiency and fatigue, with products designed to penetrate the male vitality supplement market [3] Strategic Collaborations and Investments - Dong'e Ejiao has partnered with China Resources to establish a 1 billion yuan pharmaceutical investment fund, focusing on traditional Chinese medicine and synthetic biology [3] - The company has opened a flagship health store in Hong Kong, enhancing its global presence and facilitating entry into Southeast Asian and Belt and Road markets [4] Support from Parent Company - The integration of resources from the China Resources Group has significantly improved Dong'e Ejiao's production efficiency and product quality, establishing a competitive advantage in the market [5]

Core Insights - The company reported double-digit growth in revenue and net profit for the first three quarters of 2025, indicating improved profitability and financial health [1] - The company is making significant strides in new market segments and international expansion [3] Financial Performance - For the first three quarters, the company achieved revenue of 4.766 billion yuan, a year-on-year increase of 10.10%, and a net profit of 1.274 billion yuan, up 10.58% [1] - In Q3 alone, revenue reached 1.716 billion yuan, with a net profit of 456 million yuan, reflecting year-on-year growth rates of 8.50% and 10.29% respectively [1] - The gross profit margin improved by 3.33 percentage points to 73.69% due to stable sales of core products and enhanced supply chain management [1] - Operating cash flow for the first three quarters was 1.31 billion yuan, with a net cash ratio of 1.03, indicating improved operational efficiency [1] - The asset-liability ratio stood at 21.77%, suggesting low debt risk [1] Product Performance - The company's three core products performed exceptionally well, with its Ejiao blocks and compound Ejiao syrup ranking first and second in the top 20 list of traditional Chinese medicine for replenishing qi and blood [2] - The Peach Blossom Princess Ejiao cake gained recognition through low-sugar product innovation and cross-marketing, driving repeat purchases among female consumers [2] Market Expansion - The company is targeting the silver economy and men's health sectors, innovating product forms and expanding into the elderly market [2] - The "Royal Weichang 1619" strategy aims to build a supplement matrix, with the "Zhuangben" Ejiao meat and Cistanche raw extract series expected to become a new growth engine [2] Brand Development - The company was recognized in several brand value rankings, including being listed among China's 500 most valuable brands and topping the 2025 Health China Brand Value List [2] Internationalization - The company opened its Hong Kong flagship store in October, marking a significant step in its global strategy and enhancing its dual-driven approach of "cultural export" and "industrial landing" [3]

Core Insights - The company reported a revenue of 4.41% growth year-on-year for the first three quarters of 2025, reaching 4.766 billion yuan, with a net profit increase of 10.53% to 1.274 billion yuan [1] - The gross profit margin improved by 3.33 percentage points to 73.69%, driven by stable growth in core product lines and a focus on high-margin categories [1] - The company is actively expanding into new growth areas, particularly targeting the silver economy and men's health sectors, which are expected to provide new growth momentum [3] Financial Performance - For the first three quarters, the company achieved a net cash flow from operating activities of 1.31 billion yuan and basic earnings per share of 1.9781 yuan, reflecting a year-on-year increase of 10.35% [1] - In Q3 alone, the company generated 1.716 billion yuan in revenue, marking an 8.50% increase compared to the same period last year, with a net profit of 456 million yuan, up 10.29% [1] Product Performance - The core product matrix, including Ejiao blocks, compound Ejiao syrup, and Taohua Ji Ejiao cake, continued to show robust growth, solidifying market share [2] - The company is focusing on product innovation and marketing strategies to attract diverse consumer groups, particularly through the introduction of low-sugar certified products [2] Strategic Initiatives - The company is leveraging its partnership with China Resources Group to enhance its strategic transformation and ecosystem development, including a 1 billion yuan investment fund for traditional Chinese medicine [4] - The launch of a flagship health supplement store in Hong Kong marks a significant step in the company's global expansion strategy, aiming to integrate cultural outreach with industry presence [5]